National Heart, Lung, and Blood Institute; Notice of Charter Renewal

---
identifier: "/us/fr/2021-14420"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Heart, Lung, and Blood Institute; Notice of Charter Renewal"
title_number: 0
title_name: "Federal Register"
section_number: "2021-14420"
section_name: "National Heart, Lung, and Blood Institute; Notice of Charter Renewal"
positive_law: false
currency: "2021-07-07"
last_updated: "2021-07-07"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2021-14420"
document_type: "notice"
publication_date: "2021-07-07"
agencies:
  - "Health and Human Services Department"
  - "National Institutes of Health"
fr_citation: "86 FR 35813"
fr_volume: 86
---


#  National Heart, Lung, and Blood Institute; Notice of Charter Renewal

In accordance with Title 42 of the U.S. Code of Federal Regulations, Section 217a, notice is hereby given that the Charter for the Sickle Cell Diseases Advisory Committee was renewed for an additional two-year period on June 30, 2021.

It is determined that the Sickle Cell Diseases Advisory Committee is in the public interest in connection with the performance of duties imposed on the National Institutes of Health by law, and that these duties can best be performed through the advice and counsel of this group.

Inquiries may be directed to Claire Harris, Director, Office of Federal Advisory. Committee Policy, Office of the Director, National Institutes of Health, 6701 Democracy Boulevard, Suite 1000, Bethesda, Maryland 20892 (Mail Stop Code 4875), Telephone (301) 496-2123, or *[email protected]* .

Dated: June 30, 2021.

David W. Freeman,

Program Analyst, Office of Federal Advisory Committee Policy.